Transcriptional regulation of human DUSP4 gene by cancer‐related transcription factors. Issue 10 (13th July 2021)

• Record Type: Journal Article
• Authors: Varela, Tatiana; Conceição, Natércia; Laizé, Vincent; Cancela, M. Leonor
• Is Part Of: Journal of cellular biochemistry. Volume 122:Issue 10(2021)
• Page Start: 1556
• Page End: 1566
• Publication Date: 2021-07-13
• Subjects: CTCF -- DUSP4 -- FOXA1 -- STAT3 -- transcriptional regulation -- YY1; Cytochemistry -- Periodicals; 572
• DOI: 10.1002/jcb.30078
• Languages: English
• ISSNs: 0730-2312

Abstract

Abstract: Dual specificity phosphatase 4 (DUSP4), a member of the dual specificity phosphatase family, is responsible for the dephosphorylation and inactivation of ERK, JNK and p38, which are mitogen‐activated protein kinases involved in cell proliferation, differentiation and apoptosis, but also in inflammation processes. Given its importance for cellular signalling, DUSP4 is subjected to a tight regulation and there is growing evidence that its expression is dysregulated in several tumours. However, the mechanisms underlying DUSP4 transcriptional regulation remain poorly understood. Here, we analysed the regulation of the human DUSP4 promoters 1 and 2, located upstream of exons 1 and 2, respectively, by the cancer‐related transcription factors (TFs) STAT3, FOXA1, CTCF and YY1. The presence of binding sites for these TFs was predicted in both promoters through the in silico analysis of DUSP4, and their functionality was assessed through luciferase activity assays. Regulatory activity of the TFs tested was found to be promoter‐specific. While CTCF stimulated the activity of promoter 2 that controls the transcription of variants 2 and X1, STAT3 stimulated the activity of promoter 1 that controls the transcription of variant 1. YY1 positively regulated both promoters, although to different extents. Through site‐directed mutagenesis, the functionality of YY1 binding sites present in promoter 2 was confirmed. This study provides novel insights into the transcriptional regulation of DUSP4, contributing to a better comprehension of the mechanisms of its dysregulation observed in several types of cancer. Abstract :